Alvotech

June 04, 2026 • Author: Phil Ratcliff

Item	Proposal	Vote
1	Presentation of the management reports of the board of directors of Alvotech (the “Board of Directors”) and the reports of the independent auditor (réviseur d’entreprises agréé) on Alvotech’s annual financial statements and on the consolidated financial statements of the Alvotech group for the financial year ended 31 December 2025.	Informational(5471.17)
2	Approval of Alvotech’s annual financial statements for the financial year ended 31 December 2025.	✓ For(5471.17)
3	Approval of the consolidated financial statements of the Alvotech group for the financial year ended 31 December 2025.	✓ For(5471.17)
4	Acknowledgement and allocation of result of Alvotech for the financial year ended 31 December 2025.	✓ For(5471.17)
5	Granting of discharge (quitus) to (a) Mr. Róbert Wessman, (b) Ms. Ann Merchant, (c) Ms. Lisa Graver, (d) Mr. Richard Davies, (e) Mr. Tomas Ekman, (f) Mr. Arni Hardarson and (g) Mr. Hjörleifur Pálsson for the exercise of their respective mandate as member of the Board of Directors during the financial year ended 31 December 2025.	✓ For(5471.17)
6	Acknowledgement of the resignation of Ms. Lisa Graver as director of Alvotech.	✓ For(5471.17)
7	Renewal of the mandate of Deloitte Audit as independent auditor (réviseur d’entreprises agréé) of Alvotech in relation to Alvotech’s annual financial statements and the consolidated financial statements of the Alvotech group for the financial year ending on 31 December 2026 until the annual general meeting of Alvotech approving such financial statements.	✓ For(5471.17)
8	Renewal of the mandates of (a) Mr. Róbert Wessman, (b) Ms. Ann Merchant, (c) Mr. Richard Davies, (d) Mr. Tomas Ekman, (e) Mr. Arni Hardarson and (f) Mr. Hjörleifur Pálsson as member of the Board of Directors until the annual general meeting of Alvotech approving its annual financial statements for the financial year ending on 31 December 2026.	✗ Against(5471.17)
9	Presentation of and advisory vote on the remuneration report for the Board of Directors.	✗ Against(5471.17)

Attachments

📄

ALVO_PROXY_STATEMENT.pdf 0.1 MB

📄

ALVO_AGENDA.pdf 0.2 MB

This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial's solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.